临床药师参与肾衰竭患者连续静脉-静脉血液滤过治疗下抗感染药个体化给药的药学监护
目的:探讨临床药师参与肾衰竭患者连续静脉-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)期间抗感染治疗的药学实践。方法:介绍临床药师参与会诊的1例肾衰竭合并肺部感染患者行CVVH治疗,临床药师建议万古霉素首剂给予1 g,维持剂量0.5 g/次、每12 h给药1次,达到稳态后监测血药谷浓度,根据监测结果调整万古霉素给药方案,使其谷浓度控制在15~20μg/ml内;CVVH治疗期间增大美罗培南的用量为1 g、每8 h给药1次,延长每次滴注时间至3 h。结果:万古霉素首次血药浓度监测结果为22.14μg/ml,根据Ritschel一点法调整万古霉...
Saved in:
Published in | 中国医院用药评价与分析 Vol. 16; no. 5; pp. 708 - 711 |
---|---|
Main Author | |
Format | Journal Article |
Language | Chinese |
Published |
广州医科大学附属第二医院药学部,广东广州,510260%中山大学附属第一医院药学部,广东广州,510080
2016
|
Subjects | |
Online Access | Get full text |
ISSN | 1672-2124 |
DOI | 10.14009/j.issn.1672-2124.2016.05.049 |
Cover
Abstract | 目的:探讨临床药师参与肾衰竭患者连续静脉-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)期间抗感染治疗的药学实践。方法:介绍临床药师参与会诊的1例肾衰竭合并肺部感染患者行CVVH治疗,临床药师建议万古霉素首剂给予1 g,维持剂量0.5 g/次、每12 h给药1次,达到稳态后监测血药谷浓度,根据监测结果调整万古霉素给药方案,使其谷浓度控制在15~20μg/ml内;CVVH治疗期间增大美罗培南的用量为1 g、每8 h给药1次,延长每次滴注时间至3 h。结果:万古霉素首次血药浓度监测结果为22.14μg/ml,根据Ritschel一点法调整万古霉素给药方案为0.4 g、每12 h给药1次,再次监测谷浓度为18.05μg/ml。临床药师通过治疗药物监测和个体化剂量调整保证了抗感染药治疗的有效性与安全性,促使患者的病情好转。结论:临床药师参与临床药物治疗,可对此类特殊患者开展药学服务,制订个体化抗感染给药方案,发挥在药物治疗中的作用。 |
---|---|
AbstractList | 目的:探讨临床药师参与肾衰竭患者连续静脉-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)期间抗感染治疗的药学实践。方法:介绍临床药师参与会诊的1例肾衰竭合并肺部感染患者行CVVH治疗,临床药师建议万古霉素首剂给予1 g,维持剂量0.5 g/次、每12 h给药1次,达到稳态后监测血药谷浓度,根据监测结果调整万古霉素给药方案,使其谷浓度控制在15~20μg/ml内;CVVH治疗期间增大美罗培南的用量为1 g、每8 h给药1次,延长每次滴注时间至3 h。结果:万古霉素首次血药浓度监测结果为22.14μg/ml,根据Ritschel一点法调整万古霉素给药方案为0.4 g、每12 h给药1次,再次监测谷浓度为18.05μg/ml。临床药师通过治疗药物监测和个体化剂量调整保证了抗感染药治疗的有效性与安全性,促使患者的病情好转。结论:临床药师参与临床药物治疗,可对此类特殊患者开展药学服务,制订个体化抗感染给药方案,发挥在药物治疗中的作用。 R969.3; 目的:探讨临床药师参与肾衰竭患者连续静脉-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)期间抗感染治疗的药学实践.方法:介绍临床药师参与会诊的1例肾衰竭合并肺部感染患者行CVVH治疗,临床药师建议万古霉素首剂给予1g,维持剂量0.5 g/次、每12 h给药1次,达到稳态后监测血药谷浓度,根据监测结果调整万古霉素给药方案,使其谷浓度控制在15~20 μg/ml内;CVVH治疗期间增大美罗培南的用量为1g、每8h给药1次,延长每次滴注时间至3h.结果:万古霉素首次血药浓度监测结果为22.14 μg/ml,根据Ritschel 一点法调整万古霉素给药方案为0.4 g、每12 h给药1次,再次监测谷浓度为18.05 μg/ml.临床药师通过治疗药物监测和个体化剂量调整保证了抗感染药治疗的有效性与安全性,促使患者的病情好转.结论:临床药师参与临床药物治疗,可对此类特殊患者开展药学服务,制订个体化抗感染给药方案,发挥在药物治疗中的作用. |
Author | 彭怀东 何秋毅 陈杰 黄凯鹏 王若伦 |
AuthorAffiliation | 广州医科大学附属第二医院药学部,广东广州510260 中山大学附属第一医院药学部,广东广州510080 |
AuthorAffiliation_xml | – name: 广州医科大学附属第二医院药学部,广东广州,510260%中山大学附属第一医院药学部,广东广州,510080 |
Author_FL | PENG Huaidong HUANG Kaipeng WANG Ruolun CHEN Jie HE Qiuyi |
Author_FL_xml | – sequence: 1 fullname: PENG Huaidong – sequence: 2 fullname: HE Qiuyi – sequence: 3 fullname: CHEN Jie – sequence: 4 fullname: HUANG Kaipeng – sequence: 5 fullname: WANG Ruolun |
Author_xml | – sequence: 1 fullname: 彭怀东 何秋毅 陈杰 黄凯鹏 王若伦 |
BookMark | eNo9UEtLAlEYvQuDzPwTQbtmuq95LUN6gdDGvVznYSM1mkOUrUSMyl6EoFiUSNKikEIihqT8M_PqXzRi9G0O3-E84MyBmFW0dAAWEeQRhVBZLvCmbVs8EiXMYYQpjyESeSjwkCoxEP_nZ0HSts0cxIIEMSY0DmzXefc-G-Hlq-ecetc117kKa99h7y14Gfi1x7B6HI4fgtHg574T1s-4KYS9qv8x9Ef9cHziD0dBq-06536j7de7frcZZbnOs_vV9C5awagTvcFtfVIweArubvxGfx7MGGzH1pN_mACZtdVMaoNLb61vplbSnCpShdOggDSFEaIxVZExJCoWZMQEHUNJNFQEDY0pTEeUUFlQKVIglAysGlqO6BEhkQRYmsYeMMtgVj5bKO6Xragwe5SvRFcqVIzDyVBQiGaK5AtTubpdtPJ7ZmQolc1dVq5kRVFBMoGUkl94fpfc |
ClassificationCodes | R969.3 |
ContentType | Journal Article |
Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
DOI | 10.14009/j.issn.1672-2124.2016.05.049 |
DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Pharmaceutical Practice of Clinical Pharmacists in Individual Anti-infection Treatment for Renal Failure Patient with Continuous Veno-venous Hemofiltration |
DocumentTitle_FL | Pharmaceutical Practice of Clinical Pharmacists in Individual Anti-infection Treatment for Renal Failure Patient with Continuous Veno-venous Hemofiltration |
EndPage | 711 |
ExternalDocumentID | zgyyyypjyfx201605049 669183044 |
GrantInformation_xml | – fundername: 广东省医院药学研究基金 funderid: (2016A30) |
GroupedDBID | 2RA 92L ALMA_UNASSIGNED_HOLDINGS CDYEO CQIGP W91 ~WA 2B. 4A8 92I 93N ABDBF ACUHS EOJEC OBODZ PSX TCJ TUS |
ID | FETCH-LOGICAL-c649-d051d9a33dac98203c2581a5e2076fc10fda9ae143485c419007f2cfdb3e85c73 |
ISSN | 1672-2124 |
IngestDate | Thu May 29 04:11:27 EDT 2025 Wed Feb 14 10:18:30 EST 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 5 |
Keywords | 临床药师 万古霉素 连续静脉-静脉血液滤过 Continuous veno-venous hemofiltration Vancomycin 个体化给药 Individualized dosage regimen Clinical pharmacists |
Language | Chinese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c649-d051d9a33dac98203c2581a5e2076fc10fda9ae143485c419007f2cfdb3e85c73 |
Notes | OBJECTIVE: To investigate the pharmaceutical practice of clinical pharmacists in formulating the individualized dosage regimen of anti-infective drugs for a renal failure patient with continuous veno-venous hemofiltration( CVVH). METHODS: A case of lung infection combined with renal failure undergoing CVVH therapy was reported.Clinical pharmacists recommended a loading dose of 1 g of vancomycin,followed by a maintenance dose of 0. 5 g q 12 h.Therapeutic drug monitoring was taken after plasma concentration reached steady value,the administration scheme of vancomycin was adjusted according to the monitoring results,and the trough concentration was controlled within 15-20 μg / ml. During the treatment of CVVH,the dosage of meropenem had been increased to 1 g q 8h,and the infusion time had been prolonged to 3 h. RESULTS: The first monitoring result of plasma concentration of vancomycin was 22. 14 μg / ml;according to the Ritschel one-point method,clinical pharmacists decreased vancomycin dose to 0. 4 g q12 h,and |
PageCount | 4 |
ParticipantIDs | wanfang_journals_zgyyyypjyfx201605049 chongqing_primary_669183044 |
PublicationCentury | 2000 |
PublicationDate | 2016 |
PublicationDateYYYYMMDD | 2016-01-01 |
PublicationDate_xml | – year: 2016 text: 2016 |
PublicationDecade | 2010 |
PublicationTitle | 中国医院用药评价与分析 |
PublicationTitleAlternate | Evaluation and Analysis of Drug-use in Hospitals of China |
PublicationTitle_FL | Evaluation and Analysis of Drug-Use in Hospitals of China |
PublicationYear | 2016 |
Publisher | 广州医科大学附属第二医院药学部,广东广州,510260%中山大学附属第一医院药学部,广东广州,510080 |
Publisher_xml | – name: 广州医科大学附属第二医院药学部,广东广州,510260%中山大学附属第一医院药学部,广东广州,510080 |
SSID | ssib025702234 ssib017477209 ssib001103637 ssib051368574 ssib000405437 ssib001215202 ssib036441963 ssib006563103 ssib057928707 |
Score | 2.047707 |
Snippet | 目的:探讨临床药师参与肾衰竭患者连续静脉-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)期间抗感染治疗的药学实践。方法:介绍临床药师参与会诊的1例肾衰... R969.3; 目的:探讨临床药师参与肾衰竭患者连续静脉-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)期间抗感染治疗的药学实践.方法:介绍临床药师参与会诊的1例... |
SourceID | wanfang chongqing |
SourceType | Aggregation Database Publisher |
StartPage | 708 |
SubjectTerms | 万古霉素 个体化给药 临床药师 连续静脉-静脉血液滤过 |
Title | 临床药师参与肾衰竭患者连续静脉-静脉血液滤过治疗下抗感染药个体化给药的药学监护 |
URI | http://lib.cqvip.com/qk/86765X/201605/669183044.html https://d.wanfangdata.com.cn/periodical/zgyyyypjyfx201605049 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVCAB databaseName: Nutrition and Food Sciences Database issn: 1672-2124 databaseCode: DYU dateStart: 20150101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.cabidigitallibrary.org/product/zd omitProxy: true ssIdentifier: ssib001215202 providerName: CAB International – providerCode: PRVEBS databaseName: Academic Search Ultimate - eBooks issn: 1672-2124 databaseCode: ABDBF dateStart: 20151101 customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn isFulltext: true dateEnd: 99991231 titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn omitProxy: true ssIdentifier: ssib057928707 providerName: EBSCOhost |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Na9RAFA_9APEiioq1Wnpwjqn5mmTmONlkKYKeWqinssluWjxsq23B9lRKRa1fSKGlipZi8aAUpYgsLtp_Zr_8L3xvkt2d2iJVcFmyL5Nf3uckeS-bzGjaNebEHlx3Iz2JLFuHIzHRGTOp7hUYjyKjSGP5NOHNW-7ouHNjgk709LvKU0sL89FIvHTseyX_ElVog7jiW7J_EdkOU2gAGuILS4gwLE8UYxI6xGfEd0hIiS8IEyRkhAVE5GUL0AwJlifMysAslBiL-JIQJvENEnpE-EQEJHRxk7AlxiCMIuHnCQ8R46cYTnhAOJcYSEW5frQpYw0sgKMPX0sSsL-TcWSebLGwEVhzl3CvraIv9RCyxUWGPI8ELLmtWCjBQkgikJvA1ByySnXN9EnBIEIgK9VBYIyQYA5gMxMqHDVhb0sJEA8wP8ikoNocRQhLcnCIYApzhksU5yDS9xTvU4wKc6VFIeGd_4tkyIJ2FAzpPLkTz3UhqalURszLPIWSaBcitcLAuxgU31C3gC5M9hZwP6oJLYDNq_d-0pdS5XEqNeIYLSQ82Qs6xksF0GsUgwp016GpBmmvNLO-I3L4Rf0FcjjGiUcDA0xsdKuVUzTJXHKMblYOTv1QOROLHgob6OD_g57yCPhvehrp1GJZQuB6lg7pnXMoY3CVMyNVLv-ewZRM0kvTiCNJClw2ucxSUMJIRwI-Z-rKYYTTQXx_Gwd-aWoRPrN3FpP7CDQowHq1fsuDDLtP6xd-4OeVQg1KMaXwgCTfdtV1nM5aGfgPqjqccLC9bnoOVN3dgf1srJp4d6A-auK8Fd3CkXocH5iQM1m1zTmlkbax1_9kKg5qMz1TnroLqbp8c7KcFMpTSpI_dlY7k1XnwyI91Z7Tepamz2tztcqX-re11rNP9cqj-ouVWuV5a-VHa-dz8-NeY-Vda_lB6-Bts7r3881Wa_Wxnv60dpYbX_cb1d3WwcPGfrW5sVmrPGmsbTZWtxvb68CrVvlQ-75ef7rRrG7BavPVKgrYe998_bKxtntBG8uHY7lRPZurRo9dh-tFcEmRF2y7WIg5FFV2bFFmFmjJMjw3iU0jKeI0CFCcOozG4EsozRIrToqRXYIGz76o9ZVnyqVL2nDklmIngr0Y3qormAVesiPHLCRFKyrGsTWgDXb8NTmbDkk06boccjPDcQY0knlwMrtQzU0e13MunxA3qJ1GOr3pfEXrm7-3ULoKZdh8NJT1uSGtN7g9_gurfDHe |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E4%B8%B4%E5%BA%8A%E8%8D%AF%E5%B8%88%E5%8F%82%E4%B8%8E%E8%82%BE%E8%A1%B0%E7%AB%AD%E6%82%A3%E8%80%85%E8%BF%9E%E7%BB%AD%E9%9D%99%E8%84%89-%E9%9D%99%E8%84%89%E8%A1%80%E6%B6%B2%E6%BB%A4%E8%BF%87%E6%B2%BB%E7%96%97%E4%B8%8B%E6%8A%97%E6%84%9F%E6%9F%93%E8%8D%AF%E4%B8%AA%E4%BD%93%E5%8C%96%E7%BB%99%E8%8D%AF%E7%9A%84%E8%8D%AF%E5%AD%A6%E7%9B%91%E6%8A%A4&rft.jtitle=%E4%B8%AD%E5%9B%BD%E5%8C%BB%E9%99%A2%E7%94%A8%E8%8D%AF%E8%AF%84%E4%BB%B7%E4%B8%8E%E5%88%86%E6%9E%90&rft.au=%E5%BD%AD%E6%80%80%E4%B8%9C&rft.au=%E4%BD%95%E7%A7%8B%E6%AF%85&rft.au=%E9%99%88%E6%9D%B0&rft.au=%E9%BB%84%E5%87%AF%E9%B9%8F&rft.date=2016&rft.pub=%E5%B9%BF%E5%B7%9E%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E7%AC%AC%E4%BA%8C%E5%8C%BB%E9%99%A2%E8%8D%AF%E5%AD%A6%E9%83%A8%2C%E5%B9%BF%E4%B8%9C%E5%B9%BF%E5%B7%9E%2C510260%25%E4%B8%AD%E5%B1%B1%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E7%AC%AC%E4%B8%80%E5%8C%BB%E9%99%A2%E8%8D%AF%E5%AD%A6%E9%83%A8%2C%E5%B9%BF%E4%B8%9C%E5%B9%BF%E5%B7%9E%2C510080&rft.issn=1672-2124&rft.volume=16&rft.issue=5&rft.spage=708&rft.epage=711&rft_id=info:doi/10.14009%2Fj.issn.1672-2124.2016.05.049&rft.externalDocID=zgyyyypjyfx201605049 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F86765X%2F86765X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgyyyypjyfx%2Fzgyyyypjyfx.jpg |